Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - oestradiol -

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - oestradiol; oestradiol hemihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - letrozole -

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 50 mg - tablet, enteric coated - excipient ingredients: colloidal anhydrous silica; macrogol 8000; magnesium stearate; iron oxide yellow; iron oxide red; purified talc; hypromellose; lactose monohydrate; microcrystalline cellulose; titanium dioxide; povidone; sodium starch glycollate; maize starch; methacrylic acid copolymer; peg-40 hydrogenated castor oil; steareth-2; simethicone; sorbic acid - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: purified talc; povidone; iron oxide yellow; maize starch; peg-40 hydrogenated castor oil; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; acrylates copolymer; macrogol 8000; titanium dioxide; sodium starch glycollate; steareth-2; simethicone; sorbic acid - indications as at 19 may 2004: inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

duluxgroup (australia) pty ltd - mancozeb; sulfur (s) as wettable sulfur - water dispersible granule - mancozeb carbamate-dithiocarbamate active 235.0 g/kg; sulfur (s) as wettable sulfur mineral-sulfur active 549.0 g/kg - fungicide - apple crop = apple orchard | azalea | bean | beetroot | broad bean | broccoli | brussels sprouts | cabbage | camellia or tea | c - alternaria leaf spot - a. cucumerina | angular leaf spot - p. griseola | anthracnose | anthracnose - colletotrichum spp. | bean or broad bean rust- u. viciae-fabae | bean spider mite | bitter rot | black spot | black spot on rose | black spot/scab in apple/pear | blight | brown patch | brown rot - monilinia spp. | bud mite | cercospora leaf spot | chocolate spot on bean | damping off | damping off - rhizoctonia spp. | dollar spot | downy mildew | downy mildew on cucurbit | downy mildew on lettuce | early blight (target spot) | early blight on celery | early blight or target blackspot | fly speck | freckle or scab on stone fruit | fusarium spp. | grey leaf spot | grey mould - botrytis cinerea | gummy stem blight or spur blight | helminthosporium disease | late blight or irish blight | leaf blight (a. fabae) - suppression | leaf mould of tomato | leaf spot | leaf spot - alternaria cercospora | pear scab | petal blight | phoma rot | phomopsis cane | powdery mildew | powdery mildew on cucurbit | powdery mildew on

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - bevacizumab - infusion, solution concentrate - 25mg - bevacizumab 25mg

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - bevacizumab - infusion, solution concentrate - 400mg - bevacizumab 400mg

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine, quantity: 52.5 mg - drug delivery system, transdermal - excipient ingredients: methacrylic acid copolymer; fractionated coconut oil; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-ethylhexyl acrylate; glycidyl methacrylate; titanium tetrabutylate polymer; 2-hydroxyethyl acrylate - an aid in the cessation of smoking in smokers with nicotine dependence that have relapsed in the past or experienced cravings whilst using a single form of nicotine replacement therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine, quantity: 35 mg - drug delivery system, transdermal - excipient ingredients: fractionated coconut oil; methacrylic acid copolymer; ethyl acetate; ethanol; glycidyl methacrylate; 2-hydroxyethyl acrylate; 2-ethylhexyl acrylate; titanium tetrabutylate polymer; methanol; vinyl acetate; heptane; 2-ethylhexyl acrylate/glycidyl methacrylate/2-hydroxyethyl acrylate/vinyl acetate copolymer - treatment of nicotine dependence, as an aid to smoking cessation.